For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples.
LPI (LP Information)' newest research report, the "Enzyme-Linked Immunosorbent Assay (ELISA) Testing Industry Forecast" looks at past sales and reviews total world Enzyme-Linked Immunosorbent Assay (ELISA) Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Enzyme-Linked Immunosorbent Assay (ELISA) Testing sales for 2023 through 2029. With Enzyme-Linked Immunosorbent Assay (ELISA) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzyme-Linked Immunosorbent Assay (ELISA) Testing industry.
This Insight Report provides a comprehensive analysis of the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzyme-Linked Immunosorbent Assay (ELISA) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enzyme-Linked Immunosorbent Assay (ELISA) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzyme-Linked Immunosorbent Assay (ELISA) Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing.
The global Enzyme-Linked Immunosorbent Assay (ELISA) Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors such as the growing prevalence of infectious and chronic diseases and the rising number of patient visits to hospitals.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme-Linked Immunosorbent Assay (ELISA) Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Sandwich ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Competitive ELISA
Segmentation by application
- Hospitals and Diagnostic Centers
- Research Laboratories
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Abcam
- BD
- bioMerieux
- Bio-Rad Laboratories
- Thermo Fisher Scientific